CD4 and cancer: We designed a method, called TICPE, to estimate the proportions of eight important tumor-infiltrating immune cells (B cells, CD4+ T cells, CD8+ T cells, dendritic cells (DC), monocytes, macrophages, natural killer (NK) cells, and neutrophils) in a specify type of cancer.